Pharma Commercial Mock
← All views·CI feed·API docs
AASCO
Meeting Library
ASCO Annual Meeting 2026 · Chicago, IL
56 shown of 6,210 total abstracts
  1. Abstract LBA4000LBA2026-06-04 · 14:45 CT · S406
    OlympiA-776: Lynparza (olaparib) neoadjuvant in ovarian
    J. Brahmer, F. Andre, H. Borghaei · Peter MacCallum Cancer Centre
    Plenary SessionGynecologic Cancer📄🖼️
  2. Abstract LBA4001LBA2026-06-04 · 20:15 CT · S406
    Biomarker subgroup analysis of Lynparza in HR+ breast cancer (the OlympiA-835 study)
    G. Curigliano, E. Winer, M. Reck · Chinese University of Hong Kong
    Plenary SessionBreast Cancer—Metastatic📄🖼️
  3. Abstract LBA4002LBA2026-06-04 · 18:00 CT · Arie Crown Theater
    PALOMA-981: Ibrance (palbociclib) 1L in HR+ breast cancer
    S. Antonia, H. Borghaei, L. Paz-Ares · Princess Margaret Cancer Centre
    Plenary SessionBreast Cancer—Metastatic📄🖼️
  4. Abstract LBA4003LBA2026-06-03 · 18:00 CT · S100A
    Quality of life outcomes with Kisqali in patients with HR+ breast cancer
    F. Andre, M.C. Garassino, S. Antonia · Massachusetts General Hospital
    Plenary SessionBreast Cancer—Metastatic📄🖼️
  5. Abstract LBA4004LBA2026-06-01 · 20:30 CT · Hall B1
    Biomarker subgroup analysis of Lynparza in HR+ breast cancer (the OlympiA-526 study)
    A. Spira, N. Rizvi · Johns Hopkins Kimmel Cancer Center
    Plenary SessionBreast Cancer—Metastatic📄🖼️
  6. Abstract LBA4005LBA2026-06-03 · 19:00 CT · E450
    Biomarker subgroup analysis of Imfinzi in biliary tract (the PACIFIC-541 study)
    J. Brahmer, S. Tolaney, M.C. Garassino · Stanford Cancer Institute
    Plenary SessionGastrointestinal Cancer📄🖼️
  7. Abstract LBA4006LBA2026-06-04 · 13:00 CT · Hall B1
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-899
    L. Paz-Ares, F. Andre · National Cancer Center Japan
    Plenary SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  8. Abstract LBA4007LBA2026-06-01 · 16:45 CT · S100A
    DESTINY-Breast-695: Enhertu (trastuzumab deruxtecan) 3L+ in NSCLC
    A. Spira, J. Brahmer, T. Mok, et al. · Princess Margaret Cancer Centre
    Plenary SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  9. Abstract LBA4008LBA2026-06-05 · 14:45 CT · E450
    Quality of life outcomes with Tagrisso in patients with NSCLC
    J. Brahmer, C. Saura · Vall d'Hebron Institute of Oncology
    Plenary SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  10. Abstract LBA4009LBA2026-06-04 · 21:45 CT · E450
    MONALEESA-272: Kisqali (ribociclib) 2L in HR+ breast cancer
    L. Paz-Ares, H. Rugo · Karolinska Institute
    Plenary SessionBreast Cancer—Metastatic📄🖼️
  11. Abstract LBA4010LBA2026-06-04 · 15:30 CT · S406
    Enhertu plus chemotherapy in previously untreated HR+ breast cancer: updated analysis from DESTINY-Breast-222
    H. Rugo, N. Rizvi, M.C. Garassino, et al. · Johns Hopkins Kimmel Cancer Center
    Plenary SessionBreast Cancer—Metastatic📄🖼️
  12. Abstract LBA4011LBA2026-06-03 · 19:15 CT · Hall B1
    Real-world effectiveness of Imfinzi vs standard of care in biliary tract
    N. Rizvi, M. Krop, M. Reck, et al. · National Cancer Center Japan
    Plenary SessionGastrointestinal Cancer📄🖼️
  13. Abstract LBA4012LBA2026-06-03 · 14:30 CT · E450
    Real-world effectiveness of Enhertu vs standard of care in HR+ breast cancer
    M. Reck, P. Schmid, S. Peters, et al. · Stanford Cancer Institute
    Plenary SessionBreast Cancer—Metastatic📄🖼️
  14. Abstract LBA4013LBA2026-06-01 · 19:15 CT · Arie Crown Theater
    Biomarker subgroup analysis of Ibrance in HR+ breast cancer (the PALOMA-806 study)
    J. Cortes, A. Spira · Johns Hopkins Kimmel Cancer Center
    Plenary SessionBreast Cancer—Metastatic📄🖼️
  15. Abstract LBA4014LBA2026-06-01 · 19:00 CT · Hall B1
    Real-world effectiveness of Lynparza vs standard of care in HR+ breast cancer
    L. Paz-Ares, M. Reck · Princess Margaret Cancer Centre
    Plenary SessionBreast Cancer—Metastatic📄🖼️
  16. Abstract LBA4015LBA2026-06-04 · 20:15 CT · Hall B1
    Quality of life outcomes with Ibrance in patients with HR+ breast cancer
    M. Krop, C. Robert, G. Curigliano, et al. · Dana-Farber Cancer Institute
    Plenary SessionBreast Cancer—Metastatic📄🖼️
  17. Abstract LBA4016LBA2026-06-05 · 18:00 CT · E450
    Opdivo plus chemotherapy in previously untreated HCC: updated analysis from CheckMate-44
    E. Winer, C. Robert · University of Chicago
    Plenary SessionGastrointestinal Cancer📄🖼️
  18. Abstract LBA4017LBA2026-06-02 · 20:00 CT · Hall B1
    Long-term follow-up of Verzenio adjuvant for HR+ breast cancer: MONARCH-844
    S. Modi, G. Curigliano, L. Paz-Ares, et al. · University of Chicago
    Plenary SessionBreast Cancer—Metastatic📄🖼️
  19. Abstract LBA4018LBA2026-06-05 · 13:45 CT · S406
    Quality of life outcomes with Trodelvy in patients with urothelial carcinoma
    G. Curigliano, S. Antonia, S. Peters, et al. · Mayo Clinic
    Plenary SessionGenitourinary Cancer—Kidney/Bladder📄🖼️
  20. Abstract LBA4019LBA2026-06-02 · 18:00 CT · E450
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-819 study)
    P. Schmid, S. Tolaney · Institut Gustave Roussy
    Plenary SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  21. Abstract LBA4020LBA2026-06-04 · 13:15 CT · Arie Crown Theater
    Long-term follow-up of Tecentriq 3L+ for HCC: IMpower-972
    L. Paz-Ares, H. Rugo, J. Cortes · Johns Hopkins Kimmel Cancer Center
    Plenary SessionGastrointestinal Cancer📄🖼️
  22. Abstract LBA4021LBA2026-06-01 · 16:30 CT · S406
    Verzenio plus chemotherapy in previously untreated HR+ breast cancer: updated analysis from MONARCH-838
    P. Schmid, C. Saura, S. Tolaney · Dana-Farber Cancer Institute
    Plenary SessionBreast Cancer—Metastatic📄🖼️
  23. Abstract LBA4022LBA2026-06-03 · 13:45 CT · E450
    Real-world effectiveness of Imfinzi vs standard of care in NSCLC
    J. Brahmer, G. Curigliano · Chinese University of Hong Kong
    Plenary SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  24. Abstract LBA4023LBA2026-06-05 · 15:00 CT · S100A
    DESTINY-Breast-210: Enhertu (trastuzumab deruxtecan) maintenance in NSCLC
    P. Schmid, S. Antonia, S. Tolaney · Institut Gustave Roussy
    Plenary SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  25. Abstract LBA4024LBA2026-06-02 · 20:30 CT · S100A
    Biomarker subgroup analysis of Padcev in urothelial carcinoma (the EV-706 study)
    E. Winer, M. Krop, P. Schmid · Stanford Cancer Institute
    Plenary SessionGenitourinary Cancer—Kidney/Bladder📄🖼️
  26. Abstract LBA4025LBA2026-06-03 · 20:15 CT · Hall B1
    Quality of life outcomes with Verzenio in patients with HR+ breast cancer
    H. Borghaei, R. Herbst · Memorial Sloan Kettering Cancer Center
    Plenary SessionBreast Cancer—Metastatic📄🖼️
  27. Abstract LBA4026LBA2026-06-03 · 20:15 CT · S100A
    Real-world effectiveness of Kisqali vs standard of care in HR+ breast cancer
    F. Andre, S. Peters, T. Mok, et al. · Johns Hopkins Kimmel Cancer Center
    Plenary SessionBreast Cancer—Metastatic📄🖼️
  28. Abstract LBA4027LBA2026-06-01 · 21:15 CT · S100A
    Real-world effectiveness of Tagrisso vs standard of care in NSCLC
    H. Borghaei, C. Robert, J. Cortes, et al. · Johns Hopkins Kimmel Cancer Center
    Plenary SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  29. Abstract LBA4028LBA2026-06-04 · 16:30 CT · S406
    Long-term follow-up of Tecentriq 2L for TNBC: IMpower-565
    H. Borghaei, R. Herbst, F. Andre, et al. · Dana-Farber Cancer Institute
    Plenary SessionBreast Cancer—Metastatic📄🖼️
  30. Abstract LBA4029LBA2026-06-04 · 16:15 CT · Arie Crown Theater
    Biomarker subgroup analysis of Padcev in urothelial carcinoma (the EV-134 study)
    C. Saura, T. Mok, S. Antonia, et al. · Karolinska Institute
    Plenary SessionGenitourinary Cancer—Kidney/Bladder📄🖼️
  31. Abstract LBA4030LBA2026-06-04 · 20:30 CT · S406
    Quality of life outcomes with Imfinzi in patients with SCLC
    A. Spira, J. Cortes · UCSF Helen Diller Family Comprehensive Cancer Center
    Plenary SessionLung Cancer—Small Cell📄🖼️
  32. Abstract LBA4031LBA2026-06-04 · 14:45 CT · S100A
    Biomarker subgroup analysis of Keytruda in TNBC (the KEYNOTE-405 study)
    A. Spira, H. Rugo, L. Paz-Ares · MD Anderson Cancer Center
    Plenary SessionBreast Cancer—Metastatic📄🖼️
  33. Abstract LBA4032LBA2026-06-03 · 20:45 CT · E450
    FLAURA-330: Tagrisso (osimertinib) neoadjuvant in NSCLC
    R. Herbst, T. Mok, H. Rugo, et al. · University of Chicago
    Plenary SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  34. Abstract LBA4033LBA2026-06-05 · 18:45 CT · E450
    Real-world effectiveness of Keytruda vs standard of care in SCLC
    G. Curigliano, L. Paz-Ares · Peter MacCallum Cancer Centre
    Plenary SessionLung Cancer—Small Cell📄🖼️
  35. Abstract LBA4034LBA2026-06-01 · 16:45 CT · S406
    Opdivo plus chemotherapy in previously untreated RCC: updated analysis from CheckMate-620
    E. Winer, P. Schmid, A. Spira, et al. · Johns Hopkins Kimmel Cancer Center
    Plenary SessionGenitourinary Cancer—Kidney/Bladder📄🖼️
  36. Abstract LBA4035LBA2026-06-03 · 19:00 CT · S100A
    PALOMA-358: Ibrance (palbociclib) adjuvant in HR+ breast cancer
    S. Antonia, S. Tolaney, R. Herbst, et al. · Memorial Sloan Kettering Cancer Center
    Plenary SessionBreast Cancer—Metastatic📄🖼️
  37. Abstract LBA4036LBA2026-06-01 · 14:45 CT · S100A
    Biomarker subgroup analysis of Kisqali in HR+ breast cancer (the MONALEESA-119 study)
    S. Modi, M. Krop, S. Peters, et al. · Dana-Farber Cancer Institute
    Plenary SessionBreast Cancer—Metastatic📄🖼️
  38. Abstract LBA4037LBA2026-06-04 · 18:30 CT · Hall B1
    Quality of life outcomes with Padcev in patients with urothelial carcinoma
    L. Paz-Ares, S. Peters, N. Rizvi, et al. · Princess Margaret Cancer Centre
    Plenary SessionGenitourinary Cancer—Kidney/Bladder📄🖼️
  39. Abstract LBA4038LBA2026-06-02 · 19:00 CT · Arie Crown Theater
    Biomarker subgroup analysis of Imfinzi in SCLC (the PACIFIC-597 study)
    E. Winer, J. Brahmer, N. Rizvi, et al. · UCSF Helen Diller Family Comprehensive Cancer Center
    Plenary SessionLung Cancer—Small Cell📄🖼️
  40. Abstract LBA4039LBA2026-06-02 · 16:30 CT · E450
    Long-term follow-up of Tagrisso adjuvant for NSCLC: FLAURA-664
    A. Spira, S. Peters, F. Andre, et al. · Karolinska Institute
    Plenary SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  41. Abstract LBA4040LBA2026-06-05 · 20:00 CT · Arie Crown Theater
    Long-term follow-up of Enhertu adjuvant for gastric: DESTINY-Breast-337
    L. Paz-Ares, J. Brahmer, S. Antonia, et al. · Peter MacCallum Cancer Centre
    Plenary SessionGastrointestinal Cancer📄🖼️
  42. Abstract LBA4041LBA2026-06-04 · 19:45 CT · Hall B1
    Long-term follow-up of Keytruda neoadjuvant for metastatic melanoma: KEYNOTE-744
    C. Robert, R. Herbst, L. Paz-Ares, et al. · Vall d'Hebron Institute of Oncology
    Plenary SessionMelanoma📄🖼️
  43. Abstract LBA4042LBA2026-06-05 · 13:00 CT · Hall B1
    Ibrance plus chemotherapy in previously untreated HR+ breast cancer: updated analysis from PALOMA-838
    C. Robert, L. Paz-Ares, T. Mok · Peter MacCallum Cancer Centre
    Plenary SessionBreast Cancer—Metastatic📄🖼️
  44. Abstract LBA4043LBA2026-06-01 · 14:30 CT · E450
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-910
    E. Winer, F. Andre, S. Antonia · National Cancer Center Japan
    Plenary SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  45. Abstract LBA4044LBA2026-06-05 · 16:30 CT · S406
    Long-term follow-up of Verzenio 2L for HR+ breast cancer: MONARCH-753
    J. Brahmer, C. Robert, J. Cortes · Stanford Cancer Institute
    Plenary SessionBreast Cancer—Metastatic📄🖼️
  46. Abstract LBA4045LBA2026-06-03 · 13:45 CT · S100A
    Long-term follow-up of Padcev adjuvant for urothelial carcinoma: EV-158
    M. Reck, S. Modi, M. Krop, et al. · Karolinska Institute
    Plenary SessionGenitourinary Cancer—Kidney/Bladder📄🖼️
  47. Abstract LBA4046LBA2026-06-04 · 16:30 CT · E450
    Long-term follow-up of Kisqali neoadjuvant for HR+ breast cancer: MONALEESA-223
    M. Reck, L. Paz-Ares, S. Modi · National Cancer Center Japan
    Plenary SessionBreast Cancer—Metastatic📄🖼️
  48. Abstract LBA4047LBA2026-06-03 · 13:45 CT · Arie Crown Theater
    DESTINY-Breast-605: Enhertu (trastuzumab deruxtecan) adjuvant in gastric
    S. Antonia, S. Tolaney, J. Brahmer, et al. · Princess Margaret Cancer Centre
    Plenary SessionGastrointestinal Cancer📄🖼️
  49. Abstract LBA4048LBA2026-06-04 · 19:00 CT · S100A
    KEYNOTE-612: Keytruda (pembrolizumab) 3L+ in NSCLC
    H. Borghaei, N. Rizvi, S. Modi · National Cancer Center Japan
    Plenary SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  50. Abstract LBA4049LBA2026-06-05 · 15:00 CT · Hall B1
    Real-world effectiveness of Lynparza vs standard of care in ovarian
    S. Modi, J. Cortes, G. Curigliano · National Cancer Center Japan
    Plenary SessionGynecologic Cancer📄🖼️
  51. Abstract LBA4050LBA2026-06-05 · 13:30 CT · S406
    Real-world effectiveness of Imfinzi vs standard of care in SCLC
    S. Tolaney, M.C. Garassino, R. Herbst, et al. · Vall d'Hebron Institute of Oncology
    Plenary SessionLung Cancer—Small Cell📄🖼️
  52. Abstract LBA4051LBA2026-06-04 · 14:00 CT · Arie Crown Theater
    CheckMate-276: Opdivo (nivolumab) adjuvant in NSCLC
    S. Tolaney, E. Winer, L. Paz-Ares, et al. · Dana-Farber Cancer Institute
    Plenary SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  53. Abstract LBA4052LBA2026-06-04 · 21:00 CT · S100A
    IMpower-233: Tecentriq (atezolizumab) adjuvant in TNBC
    N. Rizvi, J. Brahmer, F. Andre, et al. · UCSF Helen Diller Family Comprehensive Cancer Center
    Plenary SessionBreast Cancer—Metastatic📄🖼️
  54. Abstract LBA4053LBA2026-06-05 · 19:15 CT · Hall B1
    Imfinzi plus chemotherapy in previously untreated biliary tract: updated analysis from PACIFIC-558
    H. Rugo, T. Mok · Johns Hopkins Kimmel Cancer Center
    Plenary SessionGastrointestinal Cancer📄🖼️
  55. Abstract LBA4054LBA2026-06-05 · 18:00 CT · Arie Crown Theater
    Enhertu plus chemotherapy in previously untreated NSCLC: updated analysis from DESTINY-Breast-78
    N. Rizvi, S. Antonia · Stanford Cancer Institute
    Plenary SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  56. Abstract LBA4055LBA2026-06-01 · 18:45 CT · S406
    Quality of life outcomes with Imfinzi in patients with biliary tract
    S. Tolaney, A. Spira, P. Schmid · University of Chicago
    Plenary SessionGastrointestinal Cancer📄🖼️
© 2026 American Society of Clinical Oncology · Citations follow JCO supplement format:J Clin Oncol 44, 2026 (suppl 17; abstr XXXX). Demo mock.